Technology
Disrupting the Cell Performance Status Quo
Our proprietary technologies provide distinctive advantages over other oxidative stress mitigation solutions available in the market today. They act in two complementary ways: capturing free radicals like a sponge while also converting damaging peroxides into harmless water and oxygen. Together, these mechanisms actively control oxygen generation and significantly increase cell survival and growth.
Polymer Composite Technology was found to be effective on all cell vitality metrics than currently used bioprocessing antioxidants. In a proof-of-concept testing conducted by the Institute for Applied Life Sciences’ Cell Culture Core Facility at the University of Massachusetts Amherst and O2M Technologies showed Polymer Composite Technology to be effective in increasing cell viability significantly.
A Robust & Expanding Intellectual Property Portfolio
Currently, Xheme has seven patents pending which can be broadly divided into the following categories:
- Bioprocessing
- Stored Blood and Blood Components
- Polymers, Resins, Plastics, and Packaging materials
- Paints and Coating Formulations
- Compositional Matter-core Technology
- Additive Technology to Stop Free Radical Chain Propagation